SFC Fluidics sfc-fluidics.com


Public lists: Medical Devices (6123)

SFC Fluidics provides microfluidic technologies that enable miniaturized analytical tools, laboratories-on-a-chip, clinical diagnostics, and life science research instruments. SFC Fluidics' product lines span a diverse range of markets including point-of-care diagnostics, analytical instrumentation and laboratory liquid handling.

SFC Fluidics provides microfluidic technologies that enable miniaturized analytical tools, laboratories-on-a-chip, clinical diagnostics, and life science research instruments. SFC Fluidics' product lines span a diverse range of markets including poin...Show all

Company (Alive / Active)

Phone: 479-571-2592

Fax:

535 West Research Center Boulevard
Suite 135
Fayetteville, 72701
Arkansas, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
SFC Fluidics $3.2M Sep 20, 2018
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related SFC Fluidics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Cellpoint Diagnostics

La Jolla, California, United States
Alive / ActiveCellPoint Diagnostics is developing diagnostic, monitoring, and molecular analytical tools for cancer. Its technology captures and analyzes circulating tumor cells ("CTCs") directly from patient blood. Scientific and clinical data have demonstrated that CTCs are derived from the primary tumor, and the assessment of the number of CTCs in the blood has been shown to accurately predict survival for cancer patients.Login to see details

STARR Life Sciences

Oakmont, Pennsylvania, United States
Alive / ActiveSTARR Life Sciences' aims to improve the efficacy of medical research by creating small-animal versions of human medical diagnostic and monitoring devices.Login to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Dual latching microvalves Aug 14, 2015 Application
Automated microfluidic sample analyzer platforms for point of care Feb 13, 2015 Application